In in vitro anti-inflammatory studies, dieckol upregulates hemeoxygenase-1 (HO-1), mediating anti-inflammatory effects in macrophages, and inhibits PI3 K and AKT phosphorylation in colon cancer cells, thereby impeding cancer cell proliferation and migration [70,71]. The gene discussed is AKT1; the disease is colonic neoplasm.